Differential response to neoadjuvant hormonal therapy in prostate cancer: Predictive morphological parameters and molecular markers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Differential response to neoadjuvant hormonal therapy in prostate cancer: Predictive morphological parameters and molecular markers

Published:2019-03-02 Issue:7 Volume:79 Page:709-719
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Wang Xueli¹²,Qi Mei³,Zhang Jing⁴,Sun Xiubin⁵,Guo Hongwei⁶,Pang Yu⁷,Zhang Qian⁸,Chen Xinyi⁹,Zhang Ruifeng¹⁰,Liu Zhiyan¹³,Liu Long³,Hao Xiaomeng³,Han Bo¹³^ORCID

Affiliation:

1. The Key Laboratory of Experimental Teratology, Ministry of Education and Department of Pathology, Shandong UniversitySchool of Basic Medical SciencesJinanChina

2. Department of PathologyBinzhou City Central HospitalBinzhouChina

3. Department of PathologyShandong University QiLu HospitalJinanChina

4. Department of PharmacyShandong Provincial Hospital Affiliated to Shandong UniversityJinanChina

5. Department of StatisticsShandong University, School of Public HealthJinanChina

6. Department of Pathology Linyi People's HospitalLinyiChina

7. Department of PathologyTaian City Central HospitalTaianChina

8. Department of PathologyBinzhou Medical UniversityBinzhouChina

9. Department of PathologyQingdao Central Hospital of Qingdao University Medical CollegeQingdaoChina

10. Department of PathologyTraditional Chinese Medical Hospital of XintaiTaianChina

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.23777

Reference31 articles.

1. A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma

2. Neoadjuvant systemic therapy for urological malignancies

3. The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer

4. Ten-year Follow-up of Neoadjuvant Therapy with Goserelin Acetate and Flutamide Before Radical Prostatectomy for Clinical T3 and T4 Prostate Cancer: Update on Southwest Oncology Group Study 9109

5. Pathology of androgen deprivation therapy in prostate carcinoma. A comparative study of 173 patients

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Oncological and Functional Prognostic Value of Unconventional Histology of Prostate Cancer in Localized Disease Treated with Robotic Radical Prostatectomy: An International Multicenter 5-Year Cohort Study;European Urology Oncology;2024-06

2. The role of androgen deprivation therapy prior to radical prostatectomy in high-risk prostate cancer: a systematic review;Minerva Urology and Nephrology;2024-05

3. Neoadjuvant chemohormonal therapy before radical prostatectomy in high-risk prostate cancer: a mini-review;American Journal of Clinical and Experimental Urology;2024

4. Lymphotropic Pattern of Prostate-specific Membrane Antigen–detected Metastases Among Biochemically Recurrent Radical Prostatectomy Patients with Cribriform Disease;European Urology Focus;2023-11

5. Predictive factors associated with differential pathologic response to neoadjuvant chemohormonal therapy in high-risk localized prostate cancer;Urologic Oncology: Seminars and Original Investigations;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3